Claudin 17 Antikörper (Middle Region)
Kurzübersicht für Claudin 17 Antikörper (Middle Region) (ABIN1106719)
Target
Alle Claudin 17 (CLDN17) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Sequenz
- KQVQCTGSNE RAKAYLLGTS GVLFILTGIF VLIPVSWTAN IIIRDFYNPA
-
Kreuzreaktivität (Details)
- Species reactivity (expected):Mouse, Rat, Dog, Pig, BovineSpecies reactivity (tested):Human
-
Aufreinigung
- Purified using Protein A affinity column
-
Immunogen
- The immunogen for anti-CLDN17 antibody: synthetic peptide directed towards the middle region of human CLDN17
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Rekonstitution
- Add 100 μL of distilled water to a final concentration of 1 mg/mL.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store lyophilized at 2-8 °C or at -20 °C long term. After reconstitution store the antibody undiluted at 2-8 °C for up to one month or in aliquots at -20 °C long term.
-
-
- Claudin 17 (CLDN17)
-
Andere Bezeichnung
- Claudin-17 / CLDN17
-
Hintergrund
- CLDN17, clustered with CLDN8 at human chromosome 21q22.11, is a four-transmembrane protein with WWCC motif, defined by W-X(17-22)-W-X(2)-C-X(8-10)-C. It plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity.Synonyms: PRO1489, UNQ758
-
Gen-ID
- 26285
-
NCBI Accession
- NP_036263
-
Pathways
- Cell-Cell Junction Organization, Hepatitis C
Target
-